Login to Your Account



The First Breast Cancer Vaccine to Reach Phase III?

NeuVax CMC Hold Lifted, RXi Gears Up for Phase III

By Catherine Shaffer


Tuesday, September 13, 2011
Shares in RXi Pharmaceuticals Corp. (NASDAQ:RXII) jumped 14 percent Monday on news that the FDA had cleared a chemistry, manufacturing and controls (CMC) partial clinical hold on its lead cancer vaccine, NeuVax. Now that the Worcester, Mass.-based company has satisfied all of the FDA's requirements, it is on schedule to begin its Phase III (PRESENT) trial in early 2012.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription